Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
Zimmer Biomet (NYSE: ZBH) has received CE Mark certification for its Persona® Revision Knee System, expanding its availability in European markets. The system, which leads the $700+ million U.S. knee revision market, offers personalized solutions for revision knee arthroplasty. It features Trabecular Metal™ Technology for improved implant fixation and bone in-growth, along with modular components that enable surgeons to address complex cases with greater precision. The system's anatomic components and instrumentation are designed to streamline revision surgery while allowing intraoperative adjustments for optimal alignment and fit.
Zimmer Biomet (NYSE: ZBH) ha ricevuto la certificazione CE per il suo Persona® Revision Knee System, ampliando la sua disponibilità nei mercati europei. Questo sistema, che domina il mercato delle revisioni del ginocchio negli Stati Uniti da oltre 700 milioni di dollari, offre soluzioni personalizzate per l'arthroplastica di revisione del ginocchio. È dotato della Trabecular Metal™ Technology per un miglioramento della fissazione dell'impianto e della crescita ossea, insieme a componenti modulari che consentono ai chirurghi di affrontare casi complessi con una maggiore precisione. I componenti anatomici e gli strumenti del sistema sono progettati per semplificare l'intervento di revisione, consentendo al contempo aggiustamenti intraoperatori per un allineamento e una vestibilità ottimali.
Zimmer Biomet (NYSE: ZBH) ha recibido la certificación CE para su Persona® Revision Knee System, ampliando su disponibilidad en los mercados europeos. Este sistema, que lidera el mercado de revisiones de rodilla en EE. UU. valorado en más de 700 millones de dólares, ofrece soluciones personalizadas para la artroplastia de revisión de rodilla. Presenta la Trabecular Metal™ Technology para mejorar la fijación del implante y el crecimiento óseo, junto con componentes modulares que permiten a los cirujanos abordar casos complejos con mayor precisión. Los componentes anatómicos y la instrumentación del sistema están diseñados para simplificar la cirugía de revisión, mientras permiten ajustes intraoperatorios para una alineación y ajuste óptimos.
Zimmer Biomet (NYSE: ZBH)는 유럽 시장에서의 가용성을 확장하는 Persona® Revision Knee System의 CE 마크 인증을 받았습니다. 이 시스템은 7억 달러 이상의 미국 무릎 재수술 시장을 선도하며, 무릎 재수술을 위한 개인화된 솔루션을 제공합니다. Trabecular Metal™ Technology를 통해 개선된 임플란트 고정과 뼈 성장 촉진이 이루어지며, 복잡한 사례를 보다 정밀하게 처리할 수 있도록 해주는 모듈형 구성 요소를 특징으로 합니다. 이 시스템의 해부학적 구성 요소와 기구는 재수술 수술을 간소화하도록 설계되었으며, 최적의 정렬과 적합성을 위해 수술 중 조정이 가능합니다.
Zimmer Biomet (NYSE: ZBH) a reçu la certification CE pour son Persona® Revision Knee System, élargissant ainsi sa disponibilité sur les marchés européens. Ce système, qui domine le marché américain de la révision du genou de plus de 700 millions de dollars, propose des solutions personnalisées pour l'arthroplastie de révision du genou. Il est équipé de la Trabecular Metal™ Technology pour améliorer la fixation des implants et la croissance osseuse, ainsi que de composants modulaires permettant aux chirurgiens de traiter des cas complexes avec plus de précision. Les composants anatomiques et l'instrumentation du système sont conçus pour simplifier la chirurgie de révision tout en permettant des ajustements peropératoires pour un alignement et un ajustement optimaux.
Zimmer Biomet (NYSE: ZBH) hat die CE-Zertifizierung für sein Persona® Revision Knee System erhalten, wodurch die Verfügbarkeit auf dem europäischen Markt erweitert wird. Das System, das den über 700 Millionen US-Dollar schweren Markt für Knierevisionen in den USA anführt, bietet personalisierte Lösungen für die Kniearthroplastik. Es verfügt über die Trabecular Metal™ Technology zur Verbesserung der Implantatbefestigung und des Knochenwachstums sowie über modulare Komponenten, die es Chirurgen ermöglichen, komplexe Fälle mit höherer Präzision zu behandeln. Die anatomischen Komponenten und Instrumente des Systems sind darauf ausgelegt, die Revisionschirurgie zu optimieren und gleichzeitig intraoperative Anpassungen für optimale Ausrichtung und Passform zu ermöglichen.
- Leading position in $700+ million U.S. knee revision market
- CE Mark certification enables expansion into European markets
- Advanced Trabecular Metal™ Technology promotes better implant fixation
- None.
Insights
The CE Mark approval for the Persona® Revision Knee System represents a significant market expansion opportunity for Zimmer Biomet in the lucrative European market. The system's position as a leader in the
- The proprietary Trabecular Metal™ Technology enhances bone integration and fixation stability
- Modular design offers surgical flexibility for complex cases
- Anatomic components and streamlined instrumentation improve surgical efficiency
This expansion into Europe strengthens ZBH's competitive position in the global knee replacement market. The timing is strategic as the aging population drives increased demand for revision procedures. The system's proven track record in the U.S. market suggests strong adoption potential in Europe, which could materially impact revenue growth in the EMEA region.
WARSAW, Ind., and
"After the successful introduction of Persona Revision Knee in
The Persona Revision Knee offers a personalized fit and optimized function for patients undergoing revision knee surgery. The modular system allows for intraoperative flexibility, so surgeons can address a wide range of complex cases with precision and ease. The system features Zimmer Biomet's proprietary Trabecular Metal™ Technology, which promotes long-term bone in-growth and improves implant fixation.1 2 3
"We are excited to introduce the Persona Revision Knee to expand our industry-leading knee portfolio and to provide our customers and their patients with a system that is truly personalized, adaptable, and designed to restore natural knee motion," said Wilfred van Zuilen, Group President EMEA, Zimmer Biomet.
The Persona Revision Knee system is the leading product in the over
Surgeons can make intraoperative adjustments to achieve optimal alignment and fit for each patient, which can lead to improved stability, mobility, and implant longevity.
This launch supports Zimmer Biomet's Mission to alleviate pain and improve the quality of life for patients worldwide through innovative and clinically proven solutions.
Persona Revision Knee
For more information on the Persona Revision Knee and Zimmer Biomet's comprehensive portfolio of orthopedic products, visit https://www.zimmerbiomet.com/en/products-and-solutions/specialties/knee/persona-revision.html
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet's periodic reports filed with the
References
1 Zhang, Y., et al. Interfacial Frictional Behavior: Cancellous Bone, Cortical Bone, and a Novel Porous Tantalum Biomaterial. Journal of Musculoskeletal Research. 3(4):, 245-251, 1999.
2 Bobyn, J.D., et al. Characteristics of Bone In-growth and Interface Mechanics of a New Porous Tantalum Biomaterial. Journal of Bone and Joint Surgery (British). 81-B(5): 907, 1999.
3 Shirazi-Adl, A., et al. Experimental Determination of Friction Characteristics at the Trabecular Bone / Porous-coated Metal Interface in Cementless Implants. The Journal of Biomedical Research. 27: 167-175, 1993.
4 Internal ZBH estimates
5 Internal Data on File at Zimmer Biomet: ZRR_WA_2409_11. 2011
6 Internal Data on File at Zimmer Biomet ZRR_WA_2403_11. 2011
7 Internal Data on File at Zimmer Biomet ZRR_WA_2551_12. 2012
8 Internal Data on File at Zimmer Biomet ZTR_BI_0133_18. 2018
Media | Investors | |
Heather Zoumas-Lubeski
Melinda de Boer | David DeMartino
Zach Weiner |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-ce-mark-certification-for-persona-revision-knee-system-302307885.html
SOURCE Zimmer Biomet Holdings, Inc.
FAQ
What is the market size for Zimmer Biomet's (ZBH) Persona Revision Knee System in the US?
When did Zimmer Biomet (ZBH) receive CE Mark for Persona Revision Knee System?
What technology does Zimmer Biomet's (ZBH) Persona Revision Knee System use for implant fixation?
